2026 / 02

DOI: 10.24075/brsmu.2026.012
Copyright: © 2026 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

NGS technology as a tool for the Wilson’s disease diagnosis and severity assessment

Balashova MS1,2 , Zhuchenko NA1 , Tuluzanovskaya IG1 , Glotov OS3,4,5 , Senina OS1 , Ignatova TM6 , Asanov AYu1
About authors

1 Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

2 Petrovsky Russian Scientific Center for Surgery, Moscow, Russia

3 Moscow Scientific and Practical Center for Laboratory Research, Moscow, Russia

4 Ott Research Institute of Obstetrcis, Gynecology and Reproductive Medicine, St. Petersburg, Russia

5 Federal Scientific and Clinical Center for Infectious Diseases of the Federal Medical Biological Agency, St. Petersburg, Russia

6 State Scientific Center of the Russian Federation — Federal Medical Biophysical Center named after A. I. Burnazyan, Moscow, Russia

Correspondence should be addressed: Inna G. Tuluzanovskaya
Yelansky, 2, bld. 2, 119435, Moscow, Russia; ur.liam@77t_anni

About paper

Author contribution: Balashova MS — follow-up of patients, NGS data analysis, manuscript writing; Zhuchenko NA — literature review and analysis, manuscript writing; Tuluzanovskaya IG — follow-up of patients, literature analysis and processing, manuscript writing; Glotov OS — molecular genetic testing data preparation, manuscript editing; Senina OS — data entry, manuscript writing; Ignatova TM — literature analysis, manuscript editing; Asanov AYu — literature analysis, manuscript writing and editing.

Compliance with ethical standards: the study was approved by the Ethics Committee of the Sechenov University (protocol No. 07-23 dated 27 April 2023). All subjects or their legall representatives submitted the informed consent for participation in the study.

Received: 2026-02-24 Accepted: 2026-03-11 Published online: 2026-04-01
|
  1. Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease: A European reference network for rare liver diseases (ERN RARE-LIVER) expert consensus statement. J Hepatol. 2023; 79 (2): 508–21. DOI: 10.1016/j.jhep.2023.04.011.
  2. Chang IJ, Hahn SH. The genetics of Wilson disease. Handb Clin Neurol. 2017; 142: 19–34. DOI: 10.1016/B978-0-444-63625-6.00003-3.
  3. Przybyłkowski A, Gromadzka G, Członkowska A. Genotype-phenotype correlation in Wilson’s disease. J Neurol. 2014; 261 (8): 1467–473. DOI: 10.1007/s00415-014-7391-3.
  4. Couchonnal E, Bouchard N, Poupon J, et al. Genotype–phenotype correlations in a large cohort of Wilson disease patients in France. J Hepatol. 2024; 80 (3): 416–25. DOI: 10.1016/j.jhep.2023.11.020.
  5. Xie JJ, Wu ZY. Wilson’s disease in China. Neurosci Bull. 2017; 33 (3): 323–30. DOI: 10.1007/s12264-017-0100-8.
  6. Lepori MB, Zappu A, Incollu S, et al. Mutation analysis of the ATP7B gene in a new group of Wilson’s disease patients: contribution to diagnosis. Mol Cell Probes. 2012; 26 (4): 147–50. DOI: 10.1016/j.mcp.2012.03.007.
  7. Lu Y, Zhang J, Li R, et al. Genotype-phenotype correlation in 1337 patients with Wilson disease. Liver Int. 2023; 43 (8): 1745–56. DOI: 10.1111/liv.15627.
  8. Ryzhkova OP, Kardymon OL, Prohorchuk EB, Konovalov FA, Maslennikov AB, Stepanov VA, i dr. Rukovodstvo po interpretacii dannyh posledovatel'nosti DNK cheloveka, poluchennyh metodami massovogo parallel'nogo sekvenirovaniya (MPS) (redakciya 2018, versiya 2). Medicinskaya genetika. 2019; 18 (2): 3–23. Russian.
  9. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17 (5): 405–24. DOI: 10.1038/gim.2015.30.
  10. Tuluzanovskaya IG, Balashova MS, ZHuchenko NA, Rozina TP, Starostina EE, Glotov OS, i dr. Kliniko-geneticheskaya baza dannyh pacientov s bolezn'yu Vil'sona–Konovalova. Svidetel'stvo o gosudarstvennoj registracii bazy dannyh RF № 2024626180. 19.12.2024. Russian.
  11. Balashova MS, Tuluzanovskaya IG, Glotov OS, Glotov AS, Barbitoff YA, Fedyakov MA, et al. The spectrum of pathogenic variants of the ATP7B gene in Wilson disease in the Russian Federation. J Trace Elem Med Biol. 2020; 59: 126420. DOI: 10.1016/j.jtemb.2019.126420. Epub 2019 Oct 25.
  12. Socha P, Janczyk W, Dhawan A, Baumann U, D'Antiga L, Tanner S, et al. Wilson's Disease in Children: A Position Paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018; 66 (2): 334–44. DOI: 10.1097/MPG.0000000000001787.
  13. EASL Clinical Practice Guidelines on Wilson disease. J Hepatol. 2022; 77 (2): 545–71. DOI: 10.1016/j.jhep.2022.04.010.
  14. Ferenci P, Stremmel W, Członkowska A, et al. Age and sex but not ATP7B genotype effectively influence the clinical phenotype of Wilson disease. Hepatology. 2019; 69 (4): 1464–81. DOI: 10.1002/hep.30280.
  15. Podymova SD. Bolezn' Vil'sona–Konovalova. Osobennosti debyuta, techeniya zabolevaniya, trudnosti diagnostiki, faktory progressirovaniya. Eksperimental'naya i klinicheskaya gastroenterologiya. 2022; 204 (8): 77–83. DOI: 10.31146/1682– 8658-ecg-204–8–77–83. Russian.
  16. Ganaraja VH, Holla VV, Pal PK. Current Management of Neurological Wilson's Disease. Tremor Other Hyperkinet Mov (NY). 2025; 15: 17. DOI: 10.5334/tohm.938.
  17. Garbuz M, Ovchinnikova E, Ovchinnikova A, Vinokurova V, Aristarkhova Y, Kuziakova O, et al. Spectrum of Pathogenic Variants of the ATP7B Gene and Genotype-Phenotype Correlation in Eastern Eurasian Patient Cohorts with Wilson's Disease. Biomedicines. 2024; 12 (12): 2833. DOI: 10.3390/biomedicines12122833.
  18. Ovchinnikova EV, Garbuz MM, Ovchinnikova AA, Kumeiko VV. Epidemiology of Wilson's Disease and Pathogenic Variants of the ATP7B Gene Leading to Diversified Protein Disfunctions. Int J Mol Sci. 2024; 25 (4): 2402. DOI: 10.3390/ijms25042402.
  19. Human Genom Mutation Database. Available from: https://portal.biobaseinternational.com/hgmd/pro/start.php.
  20. Gromadzka G, Schmidt HH, Genschel J, Bochow B, Rodo M, Tarnacka B, et al. Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson's disease. Clin Genet. 2005; 68 (6): 524–32. DOI: 10.1111/j.1399-0004.2005.00528.x.
  21. European Association for the Study of the Liver. EASL-ERN Clinical Practice Guidelines on Wilson's disease. J Hepatol. 2025: S0168-8278(24)02706-5. DOI: 10.1016/j.jhep.2024.11.007.
  22. Litwin T, Gromadzka G, Członkowska A. Monozygotic twins with Wilson’s disease: a detailed phenotypic description. Mov Disord. 2012; 27 (14): 1820–1. DOI: 10.1002/mds.25205/.
  23. Sandahl TD, et al. The prevalence and spectrum of ATP7B mutations in a large cohort. Hepatology. 2022; 76 (3): 745–57. DOI: 10.1002/hep.32445
  24. Stättermayer AF, et al. Genetic modifiers of clinical presentation in Wilson disease. Hepatology. 2022; 75 (4): 912–23. DOI: 10.1002/hep.32214.
  25. Weiss KH, et al. MTHFR and COMMD1 polymorphisms influence age at diagnosis in Wilson disease. J Hepatol. 2023; 78: S213 (EASL abstract).
  26. Pfeiffenberger J, et al. Sex-specific differences in presentation and outcome of Wilson disease. Liver Int. 2023; 43 (10): 2210–9. DOI: 10.1111/liv.15678.
  27. Roberts EA, Schilsky ML. Environmental and dietary influences on copper toxicity and Wilson disease. Hepatology. 2022; 76 (6): 1625–37. DOI: 10.1002/hep.32645.
  28. Dong Y, et al. Methodological issues in genotype-phenotype studies of Wilson disease. Hepatol Int. 2024; 18 (2): 412–20. DOI: 10.1007/s12072-023-10612-4.